Cargando…

The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy

STUDY DESIGN: The study design is a retrospective cohort study. OBJECTIVE: To compare patient-reported outcomes between patients with mild versus moderate-to-severe myelopathy following surgery for cervical spondylotic myelopathy (CSM). SUMMARY OF BACKGROUND DATA: Recent studies have demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Toci, Gregory R., Canseco, Jose A., Karamian, Brian A., Chang, Michael, Grasso, Giovanni, Nicholson, Kristen, Pflug, Emily M., Russo, Glenn S., Tarazona, Daniel, Kaye, I. David, Kurd, Mark F., Hilibrand, Alan S., Woods, Barrett I., Rihn, Jeffrey A., Anderson, D. Greg, Radcliff, Kris E., Kepler, Christopher K., Vaccaro, Alexander R., Schroeder, Gregory D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978848/
https://www.ncbi.nlm.nih.gov/pubmed/35386246
http://dx.doi.org/10.4103/jcvjs.jcvjs_165_21
_version_ 1784681044318879744
author Toci, Gregory R.
Canseco, Jose A.
Karamian, Brian A.
Chang, Michael
Grasso, Giovanni
Nicholson, Kristen
Pflug, Emily M.
Russo, Glenn S.
Tarazona, Daniel
Kaye, I. David
Kurd, Mark F.
Hilibrand, Alan S.
Woods, Barrett I.
Rihn, Jeffrey A.
Anderson, D. Greg
Radcliff, Kris E.
Kepler, Christopher K.
Vaccaro, Alexander R.
Schroeder, Gregory D.
author_facet Toci, Gregory R.
Canseco, Jose A.
Karamian, Brian A.
Chang, Michael
Grasso, Giovanni
Nicholson, Kristen
Pflug, Emily M.
Russo, Glenn S.
Tarazona, Daniel
Kaye, I. David
Kurd, Mark F.
Hilibrand, Alan S.
Woods, Barrett I.
Rihn, Jeffrey A.
Anderson, D. Greg
Radcliff, Kris E.
Kepler, Christopher K.
Vaccaro, Alexander R.
Schroeder, Gregory D.
author_sort Toci, Gregory R.
collection PubMed
description STUDY DESIGN: The study design is a retrospective cohort study. OBJECTIVE: To compare patient-reported outcomes between patients with mild versus moderate-to-severe myelopathy following surgery for cervical spondylotic myelopathy (CSM). SUMMARY OF BACKGROUND DATA: Recent studies have demonstrated that decompression for CSM leads to improved quality of life when measured by patient-reported outcomes. However, it is unknown if preoperative myelopathy classification is predictive of superior postoperative improvements. MATERIALS AND METHODS: A retrospective review of patients treated surgically for CSM at a single institution from 2014 to 2015 was performed. Preoperative myelopathy severity was classified according to the modified Japanese Orthopaedic Association (mJOA) scale as either mild (≥15) or moderate-to-severe (<15). Other outcomes included neck disability index (NDI), 12-item short-form survey (SF-12), and visual analog scale (VAS) for arm and neck pain. Differences in outcomes were tested by linear mixed-effects models followed by pairwise comparisons using least square means. Multiple linear regression determined whether any baseline outcomes or demographics predicted postoperative mJOA. RESULTS: There were 67 patients with mild and 50 patients with moderate-to-severe myelopathy. Preoperatively, patients with moderate-to-severe myelopathy reported significantly worse outcomes compared to the mild group for NDI, Physical Component Score (PCS-12), and VAS arm (P = 0.031). While both groups experienced improvements in NDI, PCS-12, VAS Arm and Neck after surgery, only the moderate-to-severe patients achieved improved mJOA (+3.1 points, P < 0.001). However, mJOA was significantly worse in the moderate-to-severe when compared to the mild group postoperatively (-1.2 points, P = 0.017). Both younger age (P = 0.017, β-coefficient = −0.05) and higher preoperative mJOA (P < 0.001, β-coefficient = 0.37) predicted higher postoperative mJOA. CONCLUSIONS: Although patients with moderate-to-severe myelopathy improved for all outcomes, they did not achieve normal absolute neurological function, indicating potential irreversible spinal cord changes. Early surgical intervention should be considered in patients with mild myelopathy if they seek to prevent progressive neurological decline over time.
format Online
Article
Text
id pubmed-8978848
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89788482022-04-05 The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy Toci, Gregory R. Canseco, Jose A. Karamian, Brian A. Chang, Michael Grasso, Giovanni Nicholson, Kristen Pflug, Emily M. Russo, Glenn S. Tarazona, Daniel Kaye, I. David Kurd, Mark F. Hilibrand, Alan S. Woods, Barrett I. Rihn, Jeffrey A. Anderson, D. Greg Radcliff, Kris E. Kepler, Christopher K. Vaccaro, Alexander R. Schroeder, Gregory D. J Craniovertebr Junction Spine Original Article STUDY DESIGN: The study design is a retrospective cohort study. OBJECTIVE: To compare patient-reported outcomes between patients with mild versus moderate-to-severe myelopathy following surgery for cervical spondylotic myelopathy (CSM). SUMMARY OF BACKGROUND DATA: Recent studies have demonstrated that decompression for CSM leads to improved quality of life when measured by patient-reported outcomes. However, it is unknown if preoperative myelopathy classification is predictive of superior postoperative improvements. MATERIALS AND METHODS: A retrospective review of patients treated surgically for CSM at a single institution from 2014 to 2015 was performed. Preoperative myelopathy severity was classified according to the modified Japanese Orthopaedic Association (mJOA) scale as either mild (≥15) or moderate-to-severe (<15). Other outcomes included neck disability index (NDI), 12-item short-form survey (SF-12), and visual analog scale (VAS) for arm and neck pain. Differences in outcomes were tested by linear mixed-effects models followed by pairwise comparisons using least square means. Multiple linear regression determined whether any baseline outcomes or demographics predicted postoperative mJOA. RESULTS: There were 67 patients with mild and 50 patients with moderate-to-severe myelopathy. Preoperatively, patients with moderate-to-severe myelopathy reported significantly worse outcomes compared to the mild group for NDI, Physical Component Score (PCS-12), and VAS arm (P = 0.031). While both groups experienced improvements in NDI, PCS-12, VAS Arm and Neck after surgery, only the moderate-to-severe patients achieved improved mJOA (+3.1 points, P < 0.001). However, mJOA was significantly worse in the moderate-to-severe when compared to the mild group postoperatively (-1.2 points, P = 0.017). Both younger age (P = 0.017, β-coefficient = −0.05) and higher preoperative mJOA (P < 0.001, β-coefficient = 0.37) predicted higher postoperative mJOA. CONCLUSIONS: Although patients with moderate-to-severe myelopathy improved for all outcomes, they did not achieve normal absolute neurological function, indicating potential irreversible spinal cord changes. Early surgical intervention should be considered in patients with mild myelopathy if they seek to prevent progressive neurological decline over time. Wolters Kluwer - Medknow 2022 2022-03-09 /pmc/articles/PMC8978848/ /pubmed/35386246 http://dx.doi.org/10.4103/jcvjs.jcvjs_165_21 Text en Copyright: © 2022 Journal of Craniovertebral Junction and Spine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Toci, Gregory R.
Canseco, Jose A.
Karamian, Brian A.
Chang, Michael
Grasso, Giovanni
Nicholson, Kristen
Pflug, Emily M.
Russo, Glenn S.
Tarazona, Daniel
Kaye, I. David
Kurd, Mark F.
Hilibrand, Alan S.
Woods, Barrett I.
Rihn, Jeffrey A.
Anderson, D. Greg
Radcliff, Kris E.
Kepler, Christopher K.
Vaccaro, Alexander R.
Schroeder, Gregory D.
The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title_full The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title_fullStr The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title_full_unstemmed The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title_short The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
title_sort impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978848/
https://www.ncbi.nlm.nih.gov/pubmed/35386246
http://dx.doi.org/10.4103/jcvjs.jcvjs_165_21
work_keys_str_mv AT tocigregoryr theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT cansecojosea theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT karamianbriana theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT changmichael theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT grassogiovanni theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT nicholsonkristen theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT pflugemilym theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT russoglenns theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT tarazonadaniel theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT kayeidavid theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT kurdmarkf theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT hilibrandalans theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT woodsbarretti theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT rihnjeffreya theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT andersondgreg theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT radcliffkrise theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT keplerchristopherk theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT vaccaroalexanderr theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT schroedergregoryd theimpactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT tocigregoryr impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT cansecojosea impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT karamianbriana impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT changmichael impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT grassogiovanni impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT nicholsonkristen impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT pflugemilym impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT russoglenns impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT tarazonadaniel impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT kayeidavid impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT kurdmarkf impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT hilibrandalans impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT woodsbarretti impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT rihnjeffreya impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT andersondgreg impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT radcliffkrise impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT keplerchristopherk impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT vaccaroalexanderr impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy
AT schroedergregoryd impactofpreoperativeneurologicalsymptomseverityonpostoperativeoutcomesincervicalspondyloticmyelopathy